Pharmaceutical - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

126 to 150 of 7014 results

Ariad enlists Medison to market Iclusig in Israel

Ariad enlists Medison to market Iclusig in Israel

06-08-2014

US specialty pharma firm Ariad Pharmaceuticals has granted Israel’s Medison Pharma exclusive rights…

AlkynesAriad PharmaceuticalsIclusigIsraelLicensingOncologyOrganofluoridesPharmaceuticalPiperazines

Existing diabetes drug Victoza could be effective treatment for world’s obese

Existing diabetes drug Victoza could be effective treatment for world’s obese

06-08-2014

Pharmaceutical companies are racing to find a new form of obesity drug as patient numbers spiral and…

Anti-diabetic drugsDiabetesGastro-intestinalsGlobalMarkets & MarketingNovo NordiskPeptide hormonesPharmaceuticalVictoza

Pfizer granted European approval for Enbrel in early-stage inflammatory joint disease

Pfizer granted European approval for Enbrel in early-stage inflammatory joint disease

06-08-2014

US pharma giant Pfizer has been granted a license extension by the European Commission for Enbrel (etanercept)…

Anti-Arthritics/RheumaticsArthritisChronic, lifelong inflammatory diseaseEnbrelPfizerPharmaceuticalRegulationSpondyloarthropathyUSA

Allergan attacks Valeant’s financial results

Allergan attacks Valeant’s financial results

06-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceCanadaFinancialMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

06-08-2014

‘Digital pharma’ is by no means a new concept for pharmaceutical marketers. But what is new is that…

FinancialGlobalMarkets & MarketingPharmaceutical

Yabao and Changzhou Le Sun partner to develop early-stage oncology compound

Yabao and Changzhou Le Sun partner to develop early-stage oncology compound

06-08-2014

Chinese specialty pharma company Yabao is to partner with Changzhou Le Sun to develop Le Sun’s LS-008,…

Business FinanceChangzhouChangzhou Le SunChinaLS-008OncologyPharmaceuticalPhosphoinositide 3-kinaseResearchYabao Pharmaceutical

EU approves Roche’s Avastin for platinum-resistant recurrent ovarian cancer

EU approves Roche’s Avastin for platinum-resistant recurrent ovarian cancer

06-08-2014

The European Commission has approved the use of Swiss pharma major Roche’s blockbuster cancer drug…

AvastinEuropeOncologyPharmaceuticalRegulationRocheTreatment for women with recurrent ovarian cancer

Actavis reports 2nd-qtr revenues increase by over a third

Actavis reports 2nd-qtr revenues increase by over a third

05-08-2014

Ireland-headquartered generics major Actavis has reported a 34% boost in revenue in the second quarter…

ActavisActavis PharmaBusiness FinanceBusiness FinanceFinancialIrelandPharmaceutical

Newly-approved drugs have one in three chance of black box warning or withdrawal

Newly-approved drugs have one in three chance of black box warning or withdrawal

05-08-2014

Newly-approved drugs have a one in three chance of acquiring a black box warning, or being withdrawn…

Boxed warningCassie FrankPharmaceuticalPharmaceutical industryPublic CitizenRegulationUS Food and Drug AdministrationUSA

Medivir licenses RSV program from Boehringer Ingelheim

Medivir licenses RSV program from Boehringer Ingelheim

05-08-2014

Swedish drugmaker Medivir has entered a license agreement with German family-owned pharma major Boehringer…

Boehringer IngelheimGlobalHuman respiratory syncytial virusLicensingMedivirMononegaviralesPharmaceuticalRespiratory and PulmonaryViral diseases

THERAMetrics and Centurion Pharma collaboration in rare diseases area

THERAMetrics and Centurion Pharma collaboration in rare diseases area

05-08-2014

Switzerland’s THERAMetrics holding and Turkish drugmaker Centurion Pharma plan to cooperate in the…

aviptadilCenturion PharmaIdiopathic pulmonary fibrosisLicensingPharmaceuticalRaffaele PetroneRare diseasesSarcoidosisTHERAMetricsTurkey

Australian exports of medicine fell by 13.5% in 2013-2014

Australian exports of medicine fell by 13.5% in 2013-2014

05-08-2014

Exports of medicine from Australia fell by 13.5% in 2013-2014, the lowest level since 2005-2006, and…

AustraliaBusiness FinanceFinancialManufacturing exportersManufacturing sectorPharmaceutical

Prescription drug abuse affects one in four of Americans

Prescription drug abuse affects one in four of Americans

05-08-2014

One in four Americans admits that they have abused prescription drugs, according to a new national survey…

AnalgesiaEgalet CorporationHealthcareNational Centers for Disease Control and PreventionPharmaceuticalPrescription drug abusePurdue PharmaTarginiqUSA

Private equity firms could be looking to acquire mature GSK and Sanofi brands

Private equity firms could be looking to acquire mature GSK and Sanofi brands

05-08-2014

Private equity groups KKR and Warburg Pincus are considering a $10 billion plan to buy drug brands from…

Business FinanceFinancialGlaxoSmithKlineGlobalMylanPharmaceuticalSanofi

New blood cancer injection given green light by UK regulators

New blood cancer injection given green light by UK regulators

05-08-2014

Patients in the UK with one of the most common forms of blood cancer can now benefit from a new injection.…

Andrew DaviesLymphomaMabTheraNHSOncologyPharmaceuticalRegulationRituximabRocheUK

US and European orphan status for AbbVie’s glioblastoma candidate

US and European orphan status for AbbVie’s glioblastoma candidate

04-08-2014

Both the European Medicines Agency and the US Food and Drug Administration have granted orphan drug designation…

AbbVieABT-414Brain tumorEuropeGlioblastoma multiformeMarkets & MarketingOncologyPharmaceuticalRare diseasesRegulationUS Food and Drug AdministrationUSA

Amgen announces positive results for Phase III trial of Kyprolis in relapsed multiple myeloma

Amgen announces positive results for Phase III trial of Kyprolis in relapsed multiple myeloma

04-08-2014

USA-based Amgen, the world’s leading independent biotech firm, and its subsidiary Onyx, say their Phase…

AmgenKyprolisOncologyOnyx PharmaceuticalsPharmaceuticalResearchRobert BradwayUSA

Taiho Pharma drops orantinib Ph III trial

Taiho Pharma drops orantinib Ph III trial

04-08-2014

Japanese drugmaker Taiho Pharmaceutical says it is terminating a Phase III clinical trial (ORIENTAL trial)…

Hepatocellular carcinomaHepatologyJapanOncologyorantinibPharmaceuticalResearchS-1TACETaiho PharmaceuticalTSU-68

Vernalis achieves research milestones in Servier oncology collaborations

Vernalis achieves research milestones in Servier oncology collaborations

04-08-2014

UK biopharmaceutical company Vernalis and Servier, France’s largest independent drugmaker, say that…

FinanceFinancialFranceIan GarlandOncologyPharmaceuticalResearchServierUKVernalis

Eisai's Fycompa launches in Belgium for partial-onset seizures

Eisai's Fycompa launches in Belgium for partial-onset seizures

04-08-2014

Fycompa (perampanel), an epilepsy drug developed by Japanese dug major Eisai, launches today in Belgium.

BelgiumCentral nervous systemEisaiEpilepsyFycompaJapanNeurologicalPharmaceuticalRegulation

126 to 150 of 7014 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top